10May 2023
LDR brachytherapy offers superior tumor control to single‐fraction HDR prostate brachytherapy

LDR brachytherapy offers superior tumor control to single‐fraction HDR prostate brachytherapy

The study compared the outcomes of single-fraction high-dose-rate (HDR) brachytherapy and single-fraction low-dose-rate (LDR) brachytherapy as the only treatment for primary prostate cancer in low and intermediate-risk patients. The results showed that LDR had significantly better biochemical relapse-free survival and overall survival rates compared to HDR. The study concluded that permanent LDR prostate implant brachytherapy is a better treatment option for primary prostate cancer.

  • #urology

Like

Save

Share